A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid From a US-Based Registry
Open Access
- 20 September 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 10, 2219
- https://doi.org/10.3389/fimmu.2019.02219
Abstract
Bullous pemphigoid (BP) and mucous membrane pemphigoid (MMP) are rare chronic autoimmune disorders characterized by subepidermal blistering. For the United States, there is a limited amount of studies in BP and MMP that address disease demographics and clinical data. In order to more comprehensively examine disease demographics and clinical factors, we performed a retrospective analysis of patient-reported data of 138 BP and 165 MMP patients enrolled in the International Pemphigus & Pemphigoid Foundation (IPPF) disease registry from 2010–2016. Patient-reported data was compared to Physician/Investigator reported data generated in our own local patient population (Western New York; 19 BP and 43 MMP patients). We confirm a female predominance in BP (M:F ratio 1:2.1) and MMP (M:F ratio 1:4.3), and a late onset within the 6th decade of life (average age at diagnosis, 59.1 ± 17.5 years for BP and 54.8 ± 11.2 years for MMP). MMP patients were significantly more likely to have a delay in diagnosis >12 months than BP patients (38 vs. 21%, respectively). Similar to other autoimmune conditions, a large number of BP (34%) and MMP (35%) patients present with other co-existing autoimmune disorders, with the most common being thyroid disease for both groups. Increased illness activity was paralleled by an increase in severe limitations of daily activities. The vast majority of of both BP and MMP patients received high intensity immunosuppression (49%). However, the majority of BP patients reported therapy with prednisone combined with other immunosuppressants (40%), while the majority of MMP patients received immunosuppressants other than prednisone (55%). With the exception of age at diagnosis, the clinical and demographic findings from both the national and local datasets were largely consistent with each other, and support those reported in other countries.This publication has 37 references indexed in Scilit:
- The frequency of other autoimmune disorders in patients with ocular cicatricial pemphigoidActa Ophthalmologica, 2011
- Risk Factors for Bullous Pemphigoid in the Elderly: A Prospective Case–Control StudyJournal of Investigative Dermatology, 2011
- Pemphigus vulgaris and mucous membrane pemphigoid: Update on etiopathogenesis, oral manifestations and managementy.Journal of Clinical and Experimental Dentistry, 2011
- Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseasesJournal of Autoimmunity, 2009
- Are Individuals With an Autoimmune Disease at Higher Risk of a Second Autoimmune Disorder?American Journal of Epidemiology, 2009
- Why Is the Mortality of Bullous Pemphigoid Greater in Europe than in the US?Journal of Investigative Dermatology, 2005
- Mortality Rate of Bullous Pemphigoid in a US Medical CenterJournal of Investigative Dermatology, 2004
- Bullous pemphigoid and autoimmunityJournal of the American Academy of Dermatology, 1993
- Association of autoimmunity and cicatricial pemphigoid: Is there an immunogenetic basis?Journal of the American Academy of Dermatology, 1991
- Increased frequency of diabetes mellitus in patients with bullous pemphigoid: A case-control studyJournal of the American Academy of Dermatology, 1984